Sees Q2 revenue ~$15B, consensus $14.77B
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- AbbVie says ‘significant progress’ continues with the pipeline
- AbbVie raises FY25 revenue view to ~$59.7B from ~$59B, consensus $59.49B
- AbbVie expects any tariff impact to be in-line with peers
- Morning Movers: AbbVie, Alphabet rising following first quarter reports
- AbbVie’s Strong Financial Performance and Growth Potential Justifies Buy Rating